Virtus LifeSci Biotech Clinical Trials ETF
11 hedge funds and large institutions have $8.37M invested in Virtus LifeSci Biotech Clinical Trials ETF in 2019 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 3 closing their positions.
Holders
11
Holders Change
-3
Holders Change %
-21.43%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
4
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Royal Bank of Canada
Toronto,
Ontario, Canada
|
$3.54M |
| 2 |
2
Jane Street
New York
|
$642K |
| 3 |
3
Citadel Advisors
Miami,
Florida
|
$332K |
| 4 |
4
Morgan Stanley
New York
|
$214K |
